Skip to main content
Publish date:

HealthPartners to join Oxford University's COVID-19 vaccine trial

The Minnesota health system will enroll 1,500 people in the trial.
Author:

HealthPartners has announced that it has been chosen as one of the global partners in Oxford University's trial of a potential COVID-19 vaccine.

The Minnesota-based health system says it will enroll 1,500 people in a clinical trial to determine if the Oxford University vaccine, which has been developed along with pharma giant AstraZeneca, is effective at preventing the virus.

It's the only Minnesota company chosen for the trial, which is being conducted across 100 sites in the U.S., Peru, and Chile.

"HealthPartners is pleased to collaborate with AstraZeneca and Oxford University on this COVID-19 vaccine clinical trial," said Andrea Walsh, HealthPartners president and CEO.

"This research compliments our other efforts to advance COVID-19 testing, treatment and care and is an important part of our mission to improve health and well-being."

The Oxford vaccine is one of three that have entered the final stage of trials in the U.S., as countries and researchers around the world seek to bring a vaccine quickly to market.

Study participants have to be at least 18 years old, with researchers particularly interested in those with an increased risk of contracting the virus, such as health care workers, first-responders, and food service workers.

Those who work in other close contact professions, such as grocery workers and meat-packers, are also wanted to enroll.

They will also look to recruit those with underlying – but stable – conditions that make them more susceptible to severe forms of COVID-19 – such as diabetes, high blood pressure, and heart conditions.

There will also be an emphasis on enrolling people of color, with the Black, Native, and Latino communities having seen higher rates of the virus and "poorer outcomes."

Follow Bring Me The News on YouTube

"In order to test whether this vaccine is effective, we need to make sure we’re connecting with people who have the greatest likelihood of becoming ill,” said Charlene McEvoy, MD, HealthPartners pulmonologist.

"Then, over time, we’ll look at the data to see whether the vaccine was successful in preventing illness. Our hope is that we find those who received the vaccine have significantly lower rates of infection."

Two-thirds of enrollees will get the vaccine, the other third will get a placebo. These will be administered in two doses a month apart, with side effects including fever, fatigue and pain at the site of the vaccine, though data from earlier trials suggest it's "well tolerated."

For information on enrolling, look here.

Weather update for Sept. 2

Next Up

Chris Finch

Hawks bury Timberwolves in 3-point barrage

Without D'Angelo Russell, the Wolves couldn't keep up with the Hawks.

P.J. Fleck, Gophers football

Kirk Ciarocca returning to Gophers as offensive coordinator

The architect of the 2019 offense will look to revive the Gophers.

Klobuchar - MTP - NBC screengrab

Klobuchar says Congress should pass law to protect abortion rights

Her comments came as the Supreme Court appears poised to weaken — or gut — Roe v. Wade

MPD missing Heard - crop 1_

Police ask for public's help finding Mpls. woman missing a week

The 36-year-old hasn't been seen or heard from recently.

unsplash cold winter breath dark

Hello, winter: List of the coldest wind chills in MN Monday morning

The state went from a relatively mild start of the season, to downright frigid wind chills.

deer

1 CWD-positive deer in Brainerd Lakes area, so surveillance will continue

The CWD monitoring measures were supposed to end after this year.

unsplash - visitor patient doctor hospital emergency - crop

MN program will train, hire 1,000 nursing assistants for long-term care

The facilities are facing a severe staffing shortage.

Minnesota State Fair - main gate day 2021

Minnesota State Fair reestablishes a police department

The fair had been contracting with the Ramsey County Sheriff's Office.

teacher, covid, masks, school

Minnetonka to consider removing middle school mask requirement

The school board has been impressed by vaccination rates among middle school students.

snow, plow

Friday winter storm could hit Twin Cities, southern Minnesota

Meteorologist Sven Sundgaard is already monitoring the forecast.

Sauk Rapids Middle School street view, Minnesota - November 2018_

Teen student arrested for threats toward MN middle school

The Sauk Rapids middle school and high school were closed Monday.

_DSC0318

Rally for trans child outed during Hastings school board race draws big crowd

Hastings has been in the spotlight since the child's family was featured in a CNN story.

Related

coronavirus, covid-19

U of M becomes among first to trial new COVID-19 treatment

They're treating a patient with lung failure using a new FDA-approved technique.

coronavirus, covid-19

Here is Minnesota's COVID-19 update for Saturday, June 27

The latest update from the Minnesota Department of Health.

coronavirus

Phase III COVID-19 vaccine trial halted after 'potentially unexplained illness'

Dr. Michael Osterholm said he'd be surprised if the illness was caused by the potential vaccine.

coronavirus, covid-19

Pfizer, BioNTech SE announce their COVID-19 vaccine is 90% effective

The companies are applying for FDA approval later in November.

HealthPartners

HealthPartners to furlough 2,600 staff, executives taking pay cuts

It comes as hospital systems seek to limit the spread of the coronavirus.

Drive-up vaccine

HealthPartners opens drive-up COVID vaccine site

The healthcare provider says it's the first drive-up vaccination site in the state.

pregnant pregnancy pexels

Data shows no increased risk of miscarriage with mRNA vaccines

The research, led by Minnesota-based HealthPartners Institute, was published Thursday.